Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis.
Ali AM, P Solans B, Hesseling AC, Winckler J, Schaaf HS, Draper HR, van der Laan L, Hughes J, Fourie B, Nielsen J, Wiesner L, Garcia-Prats AJ, Savic RM. Ali AM, et al. Among authors: winckler j. Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0079423. doi: 10.1128/aac.00794-23. Epub 2023 Dec 19. Antimicrob Agents Chemother. 2024. PMID: 38112526 Free PMC article.
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
van der Laan LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, Wiesner L, de Kock M, Winckler J, Norman J, McIlleron H, Denti P, Hesseling AC. van der Laan LE, et al. Among authors: winckler j. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e00420-17. doi: 10.1128/AAC.00420-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133558 Free PMC article.
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
Garcia-Prats AJ, Schaaf HS, Draper HR, Garcia-Cremades M, Winckler J, Wiesner L, Hesseling AC, Savic RM. Garcia-Prats AJ, et al. Among authors: winckler j. PLoS Med. 2019 Apr 30;16(4):e1002789. doi: 10.1371/journal.pmed.1002789. eCollection 2019 Apr. PLoS Med. 2019. PMID: 31039153 Free PMC article.
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial.
Garcia-Prats AJ, Svensson EM, Winckler J, Draper HR, Fairlie L, van der Laan LE, Masenya M, Schaaf HS, Wiesner L, Norman J, Aarnoutse RE, Karlsson MO, Denti P, Hesseling AC. Garcia-Prats AJ, et al. Among authors: winckler j. J Antimicrob Chemother. 2021 Nov 12;76(12):3237-3246. doi: 10.1093/jac/dkab336. J Antimicrob Chemother. 2021. PMID: 34529779 Free PMC article. Clinical Trial.
Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis.
van der Laan LE, Garcia-Prats AJ, Schaaf HS, Winckler JL, Draper H, Norman J, Wiesner L, McIlleron H, Denti P, Hesseling AC. van der Laan LE, et al. Among authors: winckler jl. Front Pharmacol. 2021 Oct 8;12:722204. doi: 10.3389/fphar.2021.722204. eCollection 2021. Front Pharmacol. 2021. PMID: 34690765 Free PMC article.
Treatment outcomes and safety in children with rifampicin-resistant TB.
Lopez-Varela E, Garcia-Prats AJ, Seddon JA, Draper HR, Winckler J, van der Laan L, Palmer M, Burger WA, Schaaf HS, Hesseling AC. Lopez-Varela E, et al. Among authors: winckler j. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):133-141. doi: 10.5588/ijtld.21.0476. Int J Tuberc Lung Dis. 2022. PMID: 35086625 Free article.
100 results